These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9029089)

  • 61. [Inhibition effect of bone marrow mesenchymal stem cells on T-lymphocyte proliferation through up-regulation of CD8+CD28- T cells].
    Zhang W; Ge W; Li CH; You SG; Han Q; Deng WM; Zhao CH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Oct; 12(5):666-9. PubMed ID: 15498131
    [TBL] [Abstract][Full Text] [Related]  

  • 62. CD3zeta and CD28 down-modulation on CD8 T cells during viral infection.
    Trimble LA; Kam LW; Friedman RS; Xu Z; Lieberman J
    Blood; 2000 Aug; 96(3):1021-9. PubMed ID: 10910918
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Lack of CD28 expression on HIV-specific cytotoxic T lymphocytes is associated with disease progression.
    Gamberg J; Pardoe I; Bowmer MI; Howley C; Grant M
    Immunol Cell Biol; 2004 Feb; 82(1):38-46. PubMed ID: 14984593
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Investigation of alpha nascent polypeptide-associated complex functions in a human CD8(+) T cell ex vivo expansion model using antisense oligonucleotides.
    Al-Shanti N; Steward CG; Garland RJ; Rowbottom AW
    Immunology; 2004 Jul; 112(3):397-403. PubMed ID: 15196207
    [TBL] [Abstract][Full Text] [Related]  

  • 65. T cell activation modulates retrovirus-mediated gene expression.
    Quinn ER; Lum LG; Trevor KT
    Hum Gene Ther; 1998 Jul; 9(10):1457-67. PubMed ID: 9681417
    [TBL] [Abstract][Full Text] [Related]  

  • 66. CD28 costimulation and CD28 expression in T lymphocyte subsets in HIV-1 infection with and without progression to AIDS.
    Choremi-Papadopoulou H; Panagiotou N; Samouilidou E; Kontopidou F; Viglis V; Antoniadou A; Kosmidis J; Kordossis T
    Clin Exp Immunol; 2000 Mar; 119(3):499-506. PubMed ID: 10691923
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Platelet factor 4 inhibits proliferation and cytokine release of activated human T cells.
    Fleischer J; Grage-Griebenow E; Kasper B; Heine H; Ernst M; Brandt E; Flad HD; Petersen F
    J Immunol; 2002 Jul; 169(2):770-7. PubMed ID: 12097379
    [TBL] [Abstract][Full Text] [Related]  

  • 68. LIGHT-deficiency impairs CD8+ T cell expansion, but not effector function.
    Liu J; Schmidt CS; Zhao F; Okragly AJ; Glasebrook A; Fox N; Galbreath E; Zhang Q; Song HY; Na S; Yang DD
    Int Immunol; 2003 Jul; 15(7):861-70. PubMed ID: 12807825
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Adenosine deaminase modulation of telomerase activity and replicative senescence in human CD8 T lymphocytes.
    Parish ST; Kim S; Sekhon RK; Wu JE; Kawakatsu Y; Effros RB
    J Immunol; 2010 Mar; 184(6):2847-54. PubMed ID: 20147632
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Increased lymphocyte beta-adrenergic receptor density in progressive multiple sclerosis is specific for the CD8+, CD28- suppressor cell.
    Karaszewski JW; Reder AT; Anlar B; Kim WC; Arnason BG
    Ann Neurol; 1991 Jul; 30(1):42-7. PubMed ID: 1656847
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells.
    Brenchley JM; Karandikar NJ; Betts MR; Ambrozak DR; Hill BJ; Crotty LE; Casazza JP; Kuruppu J; Migueles SA; Connors M; Roederer M; Douek DC; Koup RA
    Blood; 2003 Apr; 101(7):2711-20. PubMed ID: 12433688
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Gene expression and generation of CD28-CD8 T cells mediated by interleukin 15.
    Godlove J; Chiu WK; Weng NP
    Exp Gerontol; 2007 May; 42(5):412-5. PubMed ID: 17204390
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Human CD8
    Liu G; Yu Y; Feng F; Zhu P; Zhang H; Zhang D; Feng X; Zhang Z; Liu Y
    BMC Immunol; 2020 Apr; 21(1):23. PubMed ID: 32349664
    [TBL] [Abstract][Full Text] [Related]  

  • 74. CD8+CD28- T cells: certainties and uncertainties of a prevalent human T-cell subset.
    Arosa FA
    Immunol Cell Biol; 2002 Feb; 80(1):1-13. PubMed ID: 11869357
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Molecular basis for checkpoints in the CD8 T cell response: tolerance versus activation.
    Mescher MF; Agarwal P; Casey KA; Hammerbeck CD; Xiao Z; Curtsinger JM
    Semin Immunol; 2007 Jun; 19(3):153-61. PubMed ID: 17382557
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Dynamics and proliferative capacities of CD8
    Pietruczuk M; Kraszula L; Kupczyk M; Kuna P; Eusebio M
    J Biol Regul Homeost Agents; 2021; 35(2):485-494. PubMed ID: 33985326
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Metabolic reprogramming of human CD8
    Jeng MY; Hull PA; Fei M; Kwon HS; Tsou CL; Kasler H; Ng CP; Gordon DE; Johnson J; Krogan N; Verdin E; Ott M
    J Exp Med; 2018 Jan; 215(1):51-62. PubMed ID: 29191913
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Activated human T cells secrete exosomes that participate in IL-2 mediated immune response signaling.
    Wahlgren J; Karlson Tde L; Glader P; Telemo E; Valadi H
    PLoS One; 2012; 7(11):e49723. PubMed ID: 23166755
    [TBL] [Abstract][Full Text] [Related]  

  • 79. IL-21 Prevents Expansion of CD8
    Xie L; Zhang Z; Zhu P; Tian K; Liu Y; Yu Y
    Transplant Proc; 2021 Sep; 53(7):2407-2414. PubMed ID: 34474914
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cytokine-driven immortalization of in vitro activated human T lymphocytes. CD28 expression correlates inversely with cell population doublings.
    Kaltoft K
    Exp Clin Immunogenet; 1998; 15(2):84-9. PubMed ID: 9691202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.